IFN inducibility of major histocompatibility antigens in tumors (Q37341021)

19 August 2017

1 reference

title

IFN inducibility of major histocompatibility antigens in tumors (English)

1 reference

19 August 2017

1

Barbara Seliger

1 reference

19 August 2017

3

Federico Garrido

1 reference

19 August 2017

Francisco Ruiz-Cabello

series ordinal

2

1 reference

19 August 2017

1 January 2008

1 reference

Advances in Cancer Research

19 August 2017

1 reference

19 August 2017

101

1 reference

19 August 2017

249-276

1 reference

Unresponsiveness to interferon associated with STAT1 protein deficiency in a gastric adenocarcinoma cell line.

19 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2900407-7

7 January 2021

The role of IFN-alpha as homeostatic agent in the inflammatory response: a balance between danger and response?

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2900407-7

7 January 2021

Interferons as pathogenic effectors in autoimmunity

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2900407-7

7 January 2021

Expression of a metastatic phenotype in IFNs-primed/TNFalpha-activated B16 murine melanoma cells: role of JAK1/PKCdelta signal transduction factors

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2900407-7

7 January 2021

Interferon-alpha resistance in renal carcinoma cells is associated with defective induction of signal transducer and activator of transcription 1 which can be restored by a supernatant of phorbol 12-myristate 13-acetate stimulated peripheral blood m

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2900407-7

7 January 2021

Regulation of murine Tap1 and Lmp2 genes in macrophages by interferon gamma is mediated by STAT1 and IRF-1.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2900407-7

7 January 2021

IFN-dependent down-regulation of the NKG2D ligand H60 on tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2900407-7

7 January 2021

HLA class I expression in metastatic melanoma correlates with tumor development during autologous vaccination.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2900407-7

7 January 2021

Alpha-interferon and its effects on signal transduction pathways

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2900407-7

7 January 2021

Different requirements for signal transducer and activator of transcription 1alpha and interferon regulatory factor 1 in the regulation of low molecular mass polypeptide 2 and transporter associated with antigen processing 1 gene expression.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2900407-7

7 January 2021

How Stat1 mediates constitutive gene expression: a complex of unphosphorylated Stat1 and IRF1 supports transcription of the LMP2 gene

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2900407-7

7 January 2021

Positive regulatory domain I-binding factor 1 mediates repression of the MHC class II transactivator (CIITA) type IV promoter

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2900407-7

7 January 2021

Dampening of IFN-gamma-inducible gene expression in human choriocarcinoma cells is due to phosphatase-mediated inhibition of the JAK/STAT-1 pathway.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2900407-7

7 January 2021

Histone acetylation regulates the cell type specific CIITA promoters, MHC class II expression and antigen presentation in tumor cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2900407-7

7 January 2021

Mechanisms of MHC class I-restricted antigen processing and cross-presentation

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2900407-7

7 January 2021

The yin and yang of type I interferon activity in bacterial infection

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2900407-7

7 January 2021

Autophagy promotes MHC class II presentation of peptides from intracellular source proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2900407-7

7 January 2021

Loss of IFN gamma receptor is an independent prognostic factor in ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2900407-7

7 January 2021

The immunobiology of cancer immunosurveillance and immunoediting

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2900407-7

7 January 2021

Interferons, immunity and cancer immunoediting

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2900407-7

7 January 2021

Bacillus Calmette Guérin triggers the IL-12/IFN-γ axis by an IRAK-4- and NEMO-dependent, non-cognate interaction between monocytes, NK, and T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2900407-7

7 January 2021

Development of IFN-gamma resistance is associated with attenuation of SOCS genes induction and constitutive expression of SOCS 3 in melanoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2900407-7

7 January 2021

MHC antigens and tumor escape from immune surveillance

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2900407-7

7 January 2021

Natural history of HLA expression during tumour development.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2900407-7

7 January 2021

Implications for immunosurveillance of altered HLA class I phenotypes in human tumours

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2900407-7

7 January 2021

Coordinated changes of histone modifications and HDAC mobilization regulate the induction of MHC class II genes by Trichostatin A.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2900407-7

7 January 2021

IFN-γ-Induced MHC Class II Expression: Transactivation of Class II Transactivator Promoter IV by IFN Regulatory Factor-1 is Regulated by Protein Kinase C-α

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2900407-7

7 January 2021

Interferon gamma-1b compared with placebo in metastatic renal-cell carcinoma. Canadian Urologic Oncology Group

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2900407-7

7 January 2021

Peptide antigen production by the proteasome: complexity provides efficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2900407-7

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2900407-7

7 January 2021

The mutation in the ATP-binding region of JAK1, identified in human uterine leiomyosarcomas, results in defective interferon-gamma inducibility of TAP1 and LMP2.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2900407-7

7 January 2021

Functional annotation of IFN-alpha-stimulated gene expression profiles from sensitive and resistant renal cell carcinoma cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2900407-7

7 January 2021

Stat1 negatively regulates angiogenesis, tumorigenicity and metastasis of tumor cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2900407-7

7 January 2021

Regulation of signal transducer and activator of transcription 1 (STAT1) and STAT1-dependent genes by RET/PTC (rearranged in transformation/papillary thyroid carcinoma) oncogenic tyrosine kinases

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2900407-7

7 January 2021

Recent advances in antigen processing and presentation

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2900407-7

7 January 2021

Phase III trial of recombinant interferon gamma in complete responders with small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2900407-7

7 January 2021

A nucleotide insertion in exon 4 is responsible for the absence of expression of an HLA-A*0301 allele in a prostate carcinoma cell line

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2900407-7

7 January 2021

Demonstration of an interferon gamma-dependent tumor surveillance system in immunocompetent mice

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2900407-7

7 January 2021

The PI3' kinase pathway in interferon signaling.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2900407-7

7 January 2021

A pooled analysis of eastern cooperative oncology group and intergroup trials of adjuvant high-dose interferon for melanoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2900407-7

7 January 2021

Effect of human leukocyte antigen class I expression of tumor cells on outcome of intravesical instillation of bacillus calmette-guerin immunotherapy for bladder cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2900407-7

7 January 2021

Generation of major histocompatibility complex class I antigens: functional interplay between proteasomes and TPPII.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2900407-7

7 January 2021

Constitutive suppressor of cytokine signaling 3 expression confers a growth advantage to a human melanoma cell line.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2900407-7

7 January 2021

Role of PKCdelta in IFN-gamma-inducible CIITA gene expression

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2900407-7

7 January 2021

Melanoma cells exhibit variable signal transducer and activator of transcription 1 phosphorylation and a reduced response to IFN-alpha compared with immune effector cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2900407-7

7 January 2021

Expression of SOCS-1, suppressor of cytokine signalling-1, in human melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2900407-7

7 January 2021

Isolated limb perfusion in primary and recurrent melanoma: indications and results

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2900407-7

7 January 2021

Combination therapy with interferon alfa-2a and interleukin-2 for the treatment of metastatic cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2900407-7

7 January 2021

Distribution of HLA class I altered phenotypes in colorectal carcinomas: high frequency of HLA haplotype loss associated with loss of heterozygosity in chromosome region 6p21.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2900407-7

7 January 2021

STAT1 regulates lipopolysaccharide- and TNF-alpha-dependent expression of transporter associated with antigen processing 1 and low molecular mass polypeptide 2 genes in macrophages by distinct mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2900407-7

7 January 2021

Activation of the MHC class II transactivator CIITA by interferon-gamma requires cooperative interaction between Stat1 and USF-1

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2900407-7

7 January 2021

IFN regulatory factor family members differentially regulate the expression of type III IFN (IFN-lambda) genes

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2900407-7

7 January 2021

Complete loss of HLA class I antigen expression on melanoma cells: a result of successive mutational events.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2900407-7

7 January 2021

A new beta 2 microglobulin mutation found in a melanoma tumor cell line

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2900407-7

7 January 2021

The human interferon alpha species and receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2900407-7

7 January 2021

Interferons, interferon-like cytokines, and their receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2900407-7

7 January 2021

Mechanisms of type-I- and type-II-interferon-mediated signalling

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2900407-7

7 January 2021

Antitumor activity of recombinant-derived interferon alpha in metastatic renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2900407-7

7 January 2021

Increased binding of IFN regulating factor 1 mediates the synergistic induction of CIITA by IFN-gamma and tumor necrosis factor-alpha in human thyroid carcinoma cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2900407-7

7 January 2021

Molecular strategies to define HLA haplotype loss in microdissected tumor cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2900407-7

7 January 2021

Stat1-dependent and -independent pathways in IFN-gamma-dependent signaling

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2900407-7

7 January 2021

Post-proteasomal antigen processing for major histocompatibility complex class I presentation

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2900407-7

7 January 2021

Patterns of constitutive and IFN-gamma inducible expression of HLA class II molecules in human melanoma cell lines.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2900407-7

7 January 2021

Distinct mechanisms of loss of IFN-gamma mediated HLA class I inducibility in two melanoma cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2900407-7

7 January 2021

Repeated BCG treatment of mouse bladder selectively stimulates small GTPases and HLA antigens and inhibits single-spanning uroplakins.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2900407-7

7 January 2021

Epigenetic inactivation of class II transactivator (CIITA) is associated with the absence of interferon-gamma-induced HLA-DR expression in colorectal and gastric cancer cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2900407-7

7 January 2021

Antigen-loading compartments for major histocompatibility complex class II molecules continuously receive input from autophagosomes

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2900407-7

7 January 2021

JAK-STAT signaling: from interferons to cytokines

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2900407-7

7 January 2021

Molecular mechanisms of HLA class I antigen abnormalities following viral infection and transformation

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2900407-7

7 January 2021

Jak1 deficiency leads to enhanced Abelson-induced B-cell tumor formation

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2900407-7

7 January 2021

IL-28, IL-29 and their class II cytokine receptor IL-28R

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2900407-7

7 January 2021

Intracellular interferon triggers Jak/Stat signaling cascade and induces p53-dependent antiviral protection.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2900407-7

7 January 2021

Type I interferons in host defense

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2900407-7

7 January 2021

Interferon-gamma differentially regulates susceptibility of lung cancer cells to telomerase-specific cytotoxic T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2900407-7

7 January 2021

Interferon signalling network in innate defence

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2900407-7

7 January 2021

Type I interferons (alpha/beta) in immunity and autoimmunity

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2900407-7

7 January 2021

Role of Stat5 in type I interferon-signaling and transcriptional regulation

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2900407-7

7 January 2021

Phase II study of alpha interferon on renal cell carcinoma. Summary of three collaborative trials

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2900407-7

7 January 2021

IL-28 and IL-29: newcomers to the interferon family

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2900407-7

7 January 2021

Transcriptional regulation of antigen presentation.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2900407-7

7 January 2021

Both the suppressor of cytokine signaling 1 (SOCS-1) kinase inhibitory region and SOCS-1 mimetic bind to JAK2 autophosphorylation site: implications for the development of a SOCS-1 antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2900407-7

7 January 2021

Modulation of signal transducers and activators of transcription 1 and 3 signaling in melanoma by high-dose IFNalpha2b.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2900407-7

7 January 2021

STAT5 contributes to interferon resistance of melanoma cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2900407-7

7 January 2021

Controlled clinical trial of interferon-gamma as postoperative surgical adjuvant therapy for colon cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2900407-7

7 January 2021

Interferon-gamma in the first-line therapy of ovarian cancer: a randomized phase III trial

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2900407-7

7 January 2021

Interferon-resistant human melanoma cells are deficient in ISGF3 components, STAT1, STAT2, and p48-ISGF3gamma.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2900407-7

7 January 2021

Coordinate regulation of the human TAP1 and LMP2 genes from a shared bidirectional promoter

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2900407-7

7 January 2021

Decreased STAT1 expression by promoter methylation in squamous cell carcinogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2900407-7

7 January 2021

Downregulation of IFN-gammaR in association with loss of Fas function is linked to tumor progression

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2900407-7

7 January 2021

The STATs of cancer--new molecular targets come of age

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2900407-7

7 January 2021

Virus interference. I. The interferon. By A. Isaacs and J. Lindenmann, 1957.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2900407-7

7 January 2021

Expression of MHC II genes

1 reference

12 December 2020

Interferon-alpha-induced activation of signal transducer and activator of transcription proteins in malignant melanoma

1 reference

12 December 2020

The immunomodulating effect of interferon-gamma intravesical instillations in preventing bladder cancer recurrence.

1 reference

12 December 2020

Beta2-microglobulin gene mutation is not a common mechanism of HLA class I total loss in human tumors

1 reference

12 December 2020

Loss of interferon-gamma inducibility of TAP1 and LMP2 in a renal cell carcinoma cell line

1 reference

12 December 2020

Treatment of chemotherapy-refractory metastatic urothelial tumors

1 reference

12 December 2020

IFN-gamma regulation of the type IV class II transactivator promoter in astrocytes

1 reference

12 December 2020

IFN-gamma-mediated coordinated transcriptional regulation of the human TAP-1 and LMP-2 genes in human renal cell carcinoma

1 reference

12 December 2020

Synergistic interaction between interferon-alpha and interferon-gamma through induced synthesis of one subunit of the transcription factor ISGF3

1 reference

12 December 2020

10.1016/S0065-230X(08)00407-7

Identifiers

DOI

1 reference

19 August 2017

1 reference

PubMed ID

19055946